RE:These Canadian Firms Are Betting BIG On U.S. Cannabis Market
Nice mention of both APH(Aphria) and BCC (The Canadian Bioceutical Corporation) in the article. Both companies will be well positioned with operations in a country (The U.S.) that dwarfs the Canadian market.
By the end of 2018 BCC is expected to have the following:
10 dispenseries in the US
9 million grams of flower
1.2 million grams of concentrate
$150 million Canadian in Revenue
50% Margins
At the 38 minute mark of the conferance call the talk about the metrics above.
Conference Call Yr End and 1st Qtr Vegas Licence soon
https://canadianbioceutical.com/wp-content/uploads/86155663.mp3
BCC still trades at a tenth the market cap of APH.
Good luck to APH and BCC stock holders.
Read more at https://www.stockhouse.com/companies/bullboard/c.bcc/the-canadian-bioceutical-corporation?postid=26786581#uXsktuPpoEQ1D0YW.99